OPPI OTC task force releases Shaping India’s OTC Policy 2018
The study calls for a well-regulated OTC framework that not only helps improve access to medicines but also supports responsible…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 123
Browsing Category
Latest Updates
Europe’s bio capacity forecast to overtake the US by 2022
According to CPhI Annual Report, the capacity growth will keep pace with demand over the next 5-years, but small companies may…
Winners of 2018 CPhI Pharma Awards announced
The awards, in their 15th edition, welcomed 365 guests to celebrate outstanding achievements in pharma across 17 different…
Lilly India launches Olumiant to treat rheumatoid arthritis
Olumiant will be available in India starting October 2018 in 4 mg and 2 mg dosage forms
Aurobindo Pharma receives US FDA approval for Azithromycin oral suspension
The product will be launched in November 2018
Aurobindo Pharma has received final approval from the US Food & Drug…
Govt aims to raise API production to cut Chinese dependence
In 2017, India imported APIs worth $ 2.5 billion from the neighbouring country
The government is working on a road map to increase…
EMA Brexit preparedness business continuity plan enters third phase
The agency has now drawn up priority lists of those guidelines and working parties, which will exceptionally continue during BCP…
Lupin launches generic Clobetasol Propionate Ointment in the US
Lupin,Clobetasol Propionate Ointment,United States Food and Drug Administration,FDA,dermatoses
Antiepileptic drugs linked to higher risk of stroke in persons with Alzheimer’s disease
The risk did not differ between old and new antiepileptic drugs; the results were published in the Journal of the American Heart…
Boehringer Ingelheim India inaugurates facility for children with special needs
The facility will educate children on how to communicate effectively and cultivate behavioural change essential in their daily…